TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
9.67
+0.07 (0.73%)
At close: Mar 9, 2026, 4:00 PM EDT
9.37
-0.30 (-3.10%)
After-hours: Mar 9, 2026, 5:56 PM EDT
TransCode Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 9 | 2 | 4 | 8 | 32 | - | |
| Market Cap Growth | 29.16% | -43.27% | -51.10% | -73.50% | - | - | |
| Enterprise Value | 6 | 1 | -3 | -0 | 9 | - | |
| Last Close Price | 9.60 | 94.36 | 6091.00 | 497486.69 | 1877587.23 | - | |
| PB Ratio | 5.61 | -1.16 | 2.52 | 2.61 | 1.56 | - | |
| P/TBV Ratio | 6.15 | - | 2.52 | 2.61 | 1.56 | - | |
| Debt / Equity Ratio | - | -0.02 | 0.28 | - | - | -0.61 | |
| Net Debt / Equity Ratio | -1.99 | 2.86 | -1.41 | -1.54 | -1.02 | -0.37 | |
| Net Debt / EBITDA Ratio | 0.17 | 0.37 | 0.12 | 0.27 | 3.41 | - | |
| Net Debt / FCF Ratio | 0.20 | 0.43 | 0.13 | 0.31 | 3.77 | -2.55 | |
| Quick Ratio | 1.02 | 2.10 | 0.79 | 1.15 | 8.22 | 2.05 | |
| Current Ratio | 1.60 | 2.56 | 1.28 | 1.70 | 8.97 | 2.05 | |
| Return on Equity (ROE) | -1763.01% | - | -759.85% | -148.57% | -80.53% | - | |
| Return on Assets (ROA) | -232.54% | -157.06% | -190.26% | -76.30% | -32.05% | -72.09% | |
| Return on Capital Employed (ROCE) | -754.60% | -346.30% | -1156.50% | -575.00% | -30.10% | -111.70% | |
| Earnings Yield | -309.21% | -714.09% | -448.43% | -207.69% | -21.44% | - | |
| FCF Yield | -165.48% | -569.30% | -437.89% | -187.57% | -17.30% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.